Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$26.65

0.95 (3.70%)

09:43
10/06/17
10/06
09:43
10/06/17
09:43

Acorda Therapeutics resumed with a Sell at Goldman Sachs

Goldman analyst Salveen Richter resumed coverage on Acorda Therapeutics with a Sell and $20 price target.

ACOR Acorda Therapeutics
$26.65

0.95 (3.70%)

08/30/17
JANY
08/30/17
NO CHANGE
Target $18
JANY
Neutral
Acorda 'embarrassed' by FDA with refusal to file, says Janney Capital
Janney Capital analyst Ken Trbovich said in a note titled "FDA embarrasses ACOR with RTF for Inbrija" that the industry has submitted 509 NDAs or BLAs in fiscal years 2013-2016 and just 5 "refusal to file" letters have been issued, leaving Acorda Therapeutics "the ignominy of being among the less than 1% to receive an RTF." He has pushed out his view of the drug's expected launch to the first half of 2019 from the first half of next year, but he has also raised his pricing assumptions for Inbrija, leaving his fair value estimate for Acorda unchanged at $18. Trbovich, who also thinks the delay may allow Sunovion's competing Parkinson's OFF rescue program to catch up, keeps a Neutral rating on Acorda shares.
08/29/17
LEER
08/29/17
NO CHANGE
LEER
Market Perform
Leerink sees Acorda Therapeutics refusal to file for CVT-301 as 'puzzling'
Leerink analyst Paul Matteis notes that Acorda Therapeutics announced that it has received a refusal to file letter for its CVT-30 NDA. The analyst says this comes as "a very significant surprise," given strong phase 3 data, 505b2 application and the device's decade long development. FDA questions are not related to clinical/safety data, but instead are conveyed as two asks regarding manufacturing, he points out. The analyst reiterates a Market Perform rating on the shares.
08/29/17
JEFF
08/29/17
NO CHANGE
Target $22
JEFF
Hold
Acorda delay probably 'speed bump' in big picture, says Jefferies
In a research note titled "Setback and Delay Doesn't Help the Bull Case - Hold," Jefferies analyst Michael Yee says that while Acorda Therapeutics' Refuse to File letter for Inbrija in Parkinson's is disappointing, the development is "probably a speed bump in the big picture." The news does, however, reinforce the general investor uncertainty in the regulatory process for the product, Yee adds. He believes that Inbrija is "most likely approvable," but admits the timelines are now unclear. Yee has a Hold rating on Acorda with a $22 price target. The stock in premarket trading is down 30%, or $7.70, to $18.00.
07/10/17
JEFF
07/10/17
INITIATION
Target $22
JEFF
Hold
Acorda Therapeutics initiated with a Hold at Jefferies
Jefferies initiated Acorda Therapeutics with a Hold and a $22 price target.

TODAY'S FREE FLY STORIES

MOS

Mosaic

$27.78

1.0176 (3.80%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

10:05
02/21/18
02/21
10:05
02/21/18
10:05
General news
More from Harker: a trade war would not be good »

More from Harker: a trade…

ABBV

AbbVie

$120.00

2.02 (1.71%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Recommendations
AbbVie analyst commentary  »

Piper says 'hard to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

10:04
02/21/18
02/21
10:04
02/21/18
10:04
General news
Existing Home Sales data reported »

January Existing Home…

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:04
02/21/18
02/21
10:04
02/21/18
10:04
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

GVA

Granite Construction

$60.01

0.0066 (0.01%)

09:52
02/21/18
02/21
09:52
02/21/18
09:52
Conference/Events
Granite Construction management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    May

CPS

Cooper-Standard

$120.74

-0.8988 (-0.74%)

09:51
02/21/18
02/21
09:51
02/21/18
09:51
Conference/Events
Cooper-Standard management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

LEXEB

Liberty Expedia Holdings

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$249.53

-0.125 (-0.05%)

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Conference/Events
Arista Networks management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 29

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/21/18
02/21
09:45
02/21/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/21/18
02/21
09:45
02/21/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

January Existing Home…

PM

Philip Morris

09:43
02/21/18
02/21
09:43
02/21/18
09:43
Earnings
Philip Morris sees Q1 EPS about 87c, including 3c of favorable currency 

Consensus is 90c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$17.25

0.025 (0.15%)

09:41
02/21/18
02/21
09:41
02/21/18
09:41
Hot Stocks
Dynavax says CDC advisory committee recommends Heplisav-B »

Dynavax announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 04

    Apr

GRMN

Garmin

$64.86

-0.35 (-0.54%)

, DUST

Direxion Daily Gold Miners Bear 3X ETF

09:40
02/21/18
02/21
09:40
02/21/18
09:40
Options
Unusually active option classes on open February 21st »

Unusual total active…

GRMN

Garmin

$64.86

-0.35 (-0.54%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

STZ

Constellation Brands, also tag STZ.B

PEP

PepsiCo

$109.48

-1.58 (-1.42%)

XRT

S&P Retail Index SPDR

P

Pandora

GM

General Motors

MA

MasterCard

NXPI

NXP Semiconductors

$125.56

7.06 (5.96%)

MCD

McDonald's

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 08

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

DKS

Dick's Sporting

09:38
02/21/18
02/21
09:38
02/21/18
09:38
Upgrade
Dick's Sporting rating change  »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
02/21/18
02/21
09:35
02/21/18
09:35
General news
Treasury 5-year auction outlook: the $35 B sale is the second leg »

Treasury 5-year auction…

LJPC

La Jolla

$33.17

-0.7 (-2.07%)

09:35
02/21/18
02/21
09:35
02/21/18
09:35
Hot Stocks
La Jolla announces treatment of first patient in Giapreza pediatric study »

La Jolla Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.